Preparing 1-perfluorohexyloctane, used for treatment of signs and symptoms of dry eye disease, by reacting perfluorohexyl compound with octene compound in presence of initiator and in solvent, and reacting perfluorohexyloctane intermediate compound with metal catalyst, reducing agent and in solvent
2023-09-14
专利权人REDDYS LAB LTD (REDY-C)
申请日期2023-09-14
专利号IN202341061776-A
成果简介NOVELTY - Preparing 1-perfluorohexyloctane (I) involves (a) reacting a perfluorohexyl compound (II) with an octene compound (III) in presence of an initiator and in a solvent or its mixture to obtain a perfluorohexyloctane intermediate compound (IV); and (b) reacting the compound (IV) with a metal catalyst, reducing agent and in a solvent or its mixture to obtain the compound (I). USE - Method for preparing 1-perfluorohexyloctane, that used for the treatment of signs and symptoms of dry eye disease. No biological data is given. ADVANTAGE - The preparation of 1-perfluorohexyloctane is simple and robust, is feasible on large scale production with ease of operation and greater yield with higher purity. DETAILED DESCRIPTION - Preparing 1-perfluorohexyloctane of formula (I), involves (a) reacting a perfluorohexyl compound of formula (II) with an octene compound of formula (III) in presence of an initiator and in a solvent or its mixture to obtain a perfluorohexyloctane intermediate compound of formula (IV); and (b) reacting the compound (IV) with a metal catalyst, reducing agent and in a solvent or its mixture to obtain the compound (I), where X=chlorine, bromine or iodine. An INDEPENDENT CLAIM is included for a method for purification of 1-perfluorohexyloctane (I) by spinning band high vacuum distillation at defined temperature.
IPC 分类号A61K-031/565 ; A61K-047/06 ; A61K-009/20 ; C09D-171/00 ; C09D-007/20
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20401
专题中国科学院新疆生态与地理研究所
作者单位
REDDYS LAB LTD (REDY-C)
推荐引用方式
GB/T 7714
MADHRA M K,BATHINI P K,PADITALA D R,et al. Preparing 1-perfluorohexyloctane, used for treatment of signs and symptoms of dry eye disease, by reacting perfluorohexyl compound with octene compound in presence of initiator and in solvent, and reacting perfluorohexyloctane intermediate compound with metal catalyst, reducing agent and in solvent. IN202341061776-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。